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ABSTRACT.
A growing number of studies have reported a link between vascular damage and glaucoma
based on optical coherence tomography angiography (OCTA) imaging. This multitude of
studies focused on diﬀerent regions of interest (ROIs) which oﬀers the possibility to draw
conclusions on the most discriminative locations to diagnose glaucoma. The objective of this
workwas to review and analyse the discriminative capacity of vascular density, retrieved from
diﬀerent ROIs, on diﬀerentiating healthy subjects from glaucoma patients. PubMedwas used
toperforma systematic reviewon the analysis of glaucomatous vasculardamageusingOCTA.
All studies up to 21 April 2019 were considered. The ROIs were analysed by region (macula,
optic disc and peripapillary region), layer (superﬁcial and deep capillary plexus, avascular,
whole retina, choriocapillaris and choroid) and sector (according to the Garway–Heathmap).
The area under receiver operator characteristic curve (AUROC) and the statistical diﬀerence
(p‐value) were used to report the importance of each ROI for diagnosing glaucoma. From 96
screened studies, 43were eligible for this review.Overall, the peripapillary region showed to be
themost discriminative regionwith the highestmeanAUROC(0.80 ± 0.09).An improvement
of the AUROC from this region is observed when a sectorial analysis is performed, with the
highest AUROCs obtained at the inferior and superior sectors of the superﬁcial capillary
plexus in the peripapillary region (0.86 ± 0.03 and 0.87 ± 0.10, respectively). The presented
work shows that glaucomatous vascular damage can be assessed using OCTA, and its added
value as a complementary feature for glaucoma diagnosis depends on the region of interest. A
sectorial analysis of the superﬁcial layer at the peripapillary region is preferable for assessing
glaucomatous vascular damage.
Key words: glaucoma – microvascular analysis – multilayer analysis – ocular blood ﬂow – opti-
cal coherence tomography angiography – regions of interest – vascular damage
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Introduction
Glaucoma is the leading cause of
irreversible blindness worldwide,
with primary open‐angle glaucoma
(POAG) as its most prevalent form
(Van Melkebeke et al. 2018). Glau-
coma is a multifactorial disease char-
acterized by the loss of neural retinal
ganglion cells. Classic theories attri-
bute glaucomatous neuronal damage
to mechanical trauma caused by ele-
vated intraocular pressure (IOP) or
to dysfunction of vascular perfusion
and subsequent optic nerve ischaemia
(Halpern & Grosskreutz 2002).
Although elevated IOP remains the
only conﬁrmed modiﬁable risk factor
for development and progression of
glaucoma (Kass & Gordon 2000;
Heijl et al. 2002; Jesus et al. 2017),
diﬀerences in vascular parameters
have been continuously reported
between glaucoma and healthy indi-
viduals, at both ocular and systemic
level (Barbosa‐Breda et al. 2019a,b).
A number of techniques, such as
ﬂuorescein angiography, colour Dop-
pler imaging, laser speckle ﬂowgraphy
and laser Doppler ﬂowmetry, have
been used in the evaluation of ocular
and retinal blood perfusion (Michelson
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et al. 1996; Sugiyama et al. 2010;
Stalmans et al. 2011; Spaide et al.
2015; Abegão Pinto et al. 2016; Bar-
bosa‐Breda et al. 2019a,b). The appli-
cation of these modalities to glaucoma
has contributed to a more comprehen-
sive assessment of the role of vascular
supply in the disease pathophysiology.
With the introduction of new imaging
modalities such as optical coherence
tomography angiography (OCTA),
standard OCT devices are now capable
of analysing retinal blood ﬂow, which
is witnessed by extensive literature
already published in ocular diseases
(Fang et al. 2016; Koustenis et al.
2017). Due to the early stage of the
technology, diﬀerent strategies have
been proposed and are currently used
to retrieve the angiographic data from
the OCT scans (e.g. the split‐spectrum
amplitude‐decorrelation angiography
(Jia et al. 2012), the OCT‐based
microangiography (Zhang & Wang
2015), the OCTA ratio analysis
(OCTARA) (Stanga et al. 2016) and
the speckle variance OCTA (Xu et al.
2014)), which may lead to variability
between results. Besides that, the qual-
ity of the OCTA scans may change
signiﬁcantly according to the acquisi-
tion parameters (e.g. number of images
to be averaged) or artefacts such as eye
movements. A number of studies have
also developed and used diﬀerent
image processing algorithms to mea-
sure the vessel density from the OCTA
images (e.g. percentage of vessel pixels
in the respective region (Yip et al.
2019), mean intensity from the grays-
cale image (Jesus et al. 2019) or fractal
analysis (Gadde et al. 2016)). Despite
the diﬀerences that may exist between
the OCTA imaging strategies and the
algorithms to compute the vessel den-
sity, signiﬁcantly lower vessel density
and blood ﬂow index in the macula
(Akil et al. 2017; Chen et al. 2017;
Chung et al. 2017; Alnawaiseh et al.
2018), optic disc (Bojikian et al. 2016;
Chen et al. 2016; Cennamo et al. 2017;
Chen et al. 2017; Chihara et al. 2017)
and peripapillary region (Akil et al.
2017; Alnawaiseh et al. 2018; Lin et al.
2019) have been observed in glaucoma
eyes in comparison with healthy ones.
For all these regions, the diagnostic
abilities increased with the severity of
glaucoma (Chen et al. 2017; Chihara
et al. 2017; Chung et al. 2017). Current
results achieved with OCTA have pre-
sented it as a potential alternative or
complementary technology for assist-
ing glaucoma diagnosis. In comparison
with the current imaging examinations
used for the diagnosis and follow‐up,
OCTA has shown to be less aﬀected by
the ﬂoor eﬀect observed on structural
OCT analysis and to require less
patient cooperation than visual ﬁeld
testing (Van Melkebeke et al. 2018).
As in many medical imaging tech-
nologies at their early development
stage, a number of approaches for esti-
mating the microvascular density based
on diﬀerent regions of interest (ROIs)
have been proposed. However, data
reported in these approaches are often
conﬂicting and/or arising from small‐
scale studies, hindering the development
of a general methodology to study
glaucomatous vascular damage.
Microvascular density measured from
OCTA has shown to be device‐depen-
dent, artefact‐dependent (e.g. eye
motion, vitreous ﬂoaters, and media
opacities) (Spaide et al. 2016; Sánchez
Brea et al. 2019) and, more importantly,
dependent on the imaged ROI. Since
OCTA imaging is restricted to a narrow
ﬁeld of view, and the acquisition of a
single image with good quality (i.e. no
movement artefacts and good contrast)
often requires a long exposure time (in
patients known to have poor ocular
surface and sometimes poor ﬁxation
capacities), it is important to ensure an
eﬃcient image acquisition, focusing ﬁrst
in the ROIs that yield more relevant
information.Moreover, the distribution
of the vascular glaucomatous damage
among retinal, choriocapillaris and
choroid layers is still under research. It
is not clear yet whether the signiﬁcant
changes observed at the choriocapillaris
and choroid are due to imaging artefacts
or due to an actual disease mechanism
(Sousa et al. 2019).
The aim of this systematic review
was to contribute to the understanding
of the role of vascular damage in
glaucoma. To that end, the review
focuses on the vascular density
retrieved from the diﬀerent ROIs that
have been studied so far in the litera-
ture, reporting which ROIs have been
found to be the most promising for
studying glaucoma.
Methods
This research adhered to the Preferred
Items for Systematic Reviews and
Meta‐analyses (PRISMA) guidelines.
Study selection
A literature search was carried out in
the PubMed database. The search
query can be found in Appendix A.
All studies that were published from
the 1 January 2014 to the 21 April 2019
were included. The inclusion criteria
for each study were as follows: (i)
primary study, (ii) mention how the
vessel density was computed, (iii) Eng-
lish language, (iv) conducted in
humans, (v) investigate glaucomatous
eyes in comparison with a healthy
control group and (vi) reports at least:
the area under the receiver operating
characteristic curve (AUROC) or the
statistical diﬀerence between the con-
trol and glaucoma groups. Four
authors (A.B., N.B., V.E. and E.F.)
screened all the titles and abstracts
independently. A full‐text screening
was carried out by two authors
(N.B. and E.F.) independently. In case
of disagreement, a third author (A.B.
or V.E.) was consulted to reach
consensus.
Data collection
The extracted data included the fol-
lowing: study characteristics, AUROC
values for diﬀerent ROIs, microvascu-
lar density mean and standard devia-
tion, and p‐values from the statistical
comparison between healthy and glau-
coma groups. If no statistical compar-
ison or p‐values were provided, only
the AUROC values were collected and
vice versa.
For every study, the following char-
acteristics were extracted: sample size
including number of patients and eyes
for each group, average age in years,
and statistical diﬀerence (p‐value)
between groups, glaucoma severity,
OCT device brand and respective
light‐source wavelength, cut‐oﬀ value
for the signal strength index (SSI) (or
similar image quality measure) used to
exclude patients/eyes and ﬁeld of view
of the OCTA image.
Data collection included the diﬀer-
ent layers: retina (including superﬁcial,
deep and avascular), choriocapillaris
and choroid (Fig. 1A); the diﬀerent
regions: macula, optic disc (OD) and
peripapillary or circumpapillary (when
a circular band around the optic disc
was considered instead of whole image)
(Fig. 1B); and the sectors according to
the Garway–Heath map (Garway‐
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Heath et al. 2000): superonasal (SN),
superotemporal (ST), temporal (T),
inferotemporal (IT), inferonasal (IN),
nasal (N) and the inside disc (D)
(Fig. 1C). The ‘whole retina’ was
treated as a layer (Fig. 1A). Moreover,
the ‘whole region’ (all the sectors com-
bined) and the ‘fovea’ (centre of the
macular region) were considered as
sectors for the purpose of this review.
Data analysis
The collected data were used to ﬁnd
which ROIs (region, layer and sector)
have been studied and their discrimi-
nating power between glaucoma and
healthy controls. Since the data analy-
sis was oriented towards the clinical
interpretation, the microvascular den-
sity was treated as a generic feature,
not taking into account the diﬀerent
mathematical approaches used to esti-
mate it.
The AUROC was considered as the
most relevant metric for evaluating
which ROIs are the most promising
for studying glaucoma, since it pro-
vides the performance measurement for
classiﬁcation problem at various
thresholds settings. The AUROC of
all ROIs included in all reviewed stud-
ies was averaged to determine a thresh-
old for selecting the studies that would
undergo a qualitative assessment (de-
scribed in section Qualitative assess-
ment). The statistically signiﬁcant
diﬀerences (given as p‐values) were
used to complement the information
provided by the AUROCs and assess
whether a ROI was relevant for diﬀer-
entiating glaucoma from healthy con-
trols.
For those studies that did not report
an AUROC, the decision to perform a
qualitative assessment was based on
the statistical comparison between the
glaucoma and the healthy group.
Hence, the ROIs that presented signif-
icant statistical diﬀerences (p‐
value < 0.05) were also qualitatively
evaluated.
Qualitative assessment
There are several characteristics in a
study that have been reported in the
literature as potentially impacting the
outcome of OCTA‐based glaucoma
assessment and thus introducing bias.
Thus, despite the high AUROC a
method may have, it does not dismiss
a careful qualitative analysis to identify
these potential sources of bias. Hence,
in this review, all the studies that
reported an AUROC value above the
threshold (mean AUROC values for all
studied ROIs), and the ability to sig-
niﬁcantly diﬀerentiate glaucoma from
healthy subjects, were qualitatively
assessed. The qualitative assessment
Fig. 1. Regions of interest (ROIs) considered in this review for the analysis of the glaucomatous vascular damage. (A) Optical coherence tomography
image showing the retinal superﬁcial capillary plexus (SC), deep capillary plexus (DC), avascular layer (AL), whole retina (WR), choriocapillaris (CC)
and choroid (CH). (B) Fundus image highlighting the macula, optic disc (OD) and peripapillary regions. (C) Optical coherence tomography
angiography image with a circumpapillary representation of the Garway–Heath sectors: superonasal (SN), superotemporal (ST), temporal (T),
inferotemporal (IT), inferonasal (IN) and nasal (N).
Fig. 2. Flowchart of the study selection.
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Table 1. Area under the receiver operating characteristic curve (AUROC) for diﬀerentiating glaucoma eyes from healthy controls according to the
region, layer and sector for all reviewed studies.
Sector
Region
Optic disc Macula Peripapillary region
1. Superﬁcial capillary plexus
Whole image/region 0.92 (Yip et al. 2019)
0.78 (Shin et al. 2017)
0.77 (Rao et al. 2017c)
0.76 (Rao et al. 2017b)
0.75 (Alnawaiseh et al. 2018)
0.73 (Rao et al. 2017a)
0.57 (Chung et al. 2017)
0.57 (Chen et al. 2016)
0.96 (Takusagawa et al. 2017)
0.94 (Rabiolo et al. 2018)
0.94 (Chung et al. 2017)
0.94 (Chen et al. 2017)
0.92 (Rabiolo et al. 2018)
0.84 (Yip et al. 2019)
0.84 (Rabiolo et al. 2018)
0.84 (Rabiolo et al. 2018)
0.82 (Rabiolo et al. 2018)
0.80 (Kurysheva et al. 2018)
0.79 (Rabiolo et al. 2018)
0.78 (Lommatzsch et al. 2018)
0.77 (Rabiolo et al. 2018)
0.75 (Kurysheva et al. 2018)
0.71 (Rao et al. 2017c)
0.70 (Triolo et al. 2017)
0.70 (Rao et al. 2017d)
0.69 (Alnawaiseh et al. 2018)
0.67 (Rao et al. 2017c)*
0.52 (Kwon et al. 2017)
0.96 (Akil et al. 2017)
0.96 (Akil et al. 2017)
0.94 (Yarmohammadi et al. 2016a)
0.93 (Chen et al. 2017)
0.90 (Akil et al. 2017)
0.90 (Rolle et al. 2019)
0.88 (Triolo et al. 2017)
0.85 (Rao et al. 2017d)
0.85 (Rao et al. 2017b)
0.83 (Rao et al. 2017a)
0.82 (Akil et al. 2017)
0.81 (Chung et al. 2017)
0.80 (Cennamo et al. 2017)
0.80 (Kurysheva et al. 2018)
0.78 (Lommatzsch et al. 2018)
0.76 (Akil et al. 2017)
0.76 (Akil et al. 2017)
0.69 (Alnawaiseh et al. 2018)
Inside disc 0.91 (Rao et al. 2017b)
0.81 (Alnawaiseh et al. 2018)
0.72 (Rolle et al. 2019)
0.60 (Kiyota et al. 2018)
Superior 0.95 (Geyman et al. 2017)
0.78 (Shin et al. 2017)
0.73 (Rao et al. 2017d)
0.98 (Takusagawa et al. 2017)
0.79 (Kurysheva et al. 2018)
0.69 (Lommatzsch et al. 2018)
0.67 (Lommatzsch et al. 2018)
0.65 (Rao et al. 2017b)
0.65 (Rao et al. 2017d)
0.63 (Rao et al. 2017a)
0.56 (Triolo et al. 2017)
1.00 (Akil et al. 2017)
0.98 (Akil et al. 2017)
0.95 (Chung et al. 2017)
0.86 (Chung et al. 2017)
0.82 (Rao et al. 2017d)
0.77 (Rao et al. 2017b)
0.74 (Triolo et al. 2017)
Inferior 0.89 (Geyman et al. 2017)
0.84 (Shin et al. 2017)
0.67 (Rao et al. 2017d)
0.98 (Takusagawa et al. 2017)
0.69 (Kurysheva et al. 2018)
0.69 (Rao et al. 2017d)
0.68 (Lommatzsch et al. 2018)
0.68 (Lommatzsch et al. 2018)
0.61 (Rao et al. 2017a)
0.54 (Triolo et al. 2017)
0.89 (Chung et al. 2017)
0.88 (Rao et al. 2017d)
0.86 (Chung et al. 2017)
0.80 (Triolo et al. 2017)
Nasal 0.74 (Rao et al. 2017d)
0.70 (Rao et al. 2017a)
0.54 (Shin et al. 2017)
0.70 (Kurysheva et al. 2018)
0.68 (Lommatzsch et al. 2018)
0.68 (Lommatzsch et al. 2018)
0.65 (Rao et al. 2017d)
0.56 (Rao et al. 2017a)
0.86 (Kurysheva et al. 2018)
0.85 (Chung et al. 2017)
0.84 (Rao et al. 2016)
0.82 (Chung et al. 2017)
0.78 (Rao et al. 2017d)
0.73 (Triolo et al. 2017)
0.72 (Rao et al. 2017b)
0.70 (Rao et al. 2017a)
0.59 (Rolle et al. 2019)
Temporal 0.71 (Shin et al. 2017)
0.70 (Rao et al. 2017d)
0.74 (Kurysheva et al. 2018)
0.72 (Lommatzsch et al. 2018)
0.71 (Lommatzsch et al. 2018)
0.67 (Rao et al. 2017d)
0.64 (Rao et al. 2017a)
0.86 (Chung et al. 2017)
0.83 (Chung et al. 2017)
0.79 (Kurysheva et al. 2018)
0.75 (Rolle et al. 2019)
0.70 (Rao et al. 2017a)
0.68 (Triolo et al. 2017)
0.68 (Rao et al. 2017d)
0.48 (Rao et al. 2016)
Temporal superior 0.71 (Rao et al. 2017a) 0.58 (Triolo et al. 2017) 0.83 (Rao et al. 2017b)
0.81 (Kurysheva et al. 2018)
0.76 (Rao et al. 2017a)
0.71 (Rao et al. 2017c)*
0.71 (Rao et al. 2017c)
0.68 (Rao et al. 2016)
0.56 (Rolle et al. 2019)
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Table 1. (Continued)
Sector
Region
Optic disc Macula Peripapillary region
Nasal superior 0.83 (Geyman et al. 2017)
0.61 (Rao et al. 2017a)
0.59 (Rao et al. 2017a)
0.62 (Triolo et al. 2017) 0.78 (Kurysheva et al. 2018)
0.78 (Rao et al. 2017b)
0.72 (Rao et al. 2016)
0.70 (Rao et al. 2017a)
0.65 (Rolle et al. 2019)
Temporal inferior 0.61 (Rao et al. 2017a) 0.61 (Triolo et al. 2017) 0.94 (Kurysheva et al. 2018)
0.89 (Rao et al. 2017a)
0.88 (Rao et al. 2016)
0.84 (Rao et al. 2017b)
0.83 (Rao et al. 2017c)
0.75 (Rao et al. 2017c)*
0.75 (Rolle et al. 2019)
Nasal inferior 0.59 (Triolo et al. 2017) 0.88 (Kurysheva et al. 2018)
0.81 (Rao et al. 2017a)
0.78 (Rao et al. 2017b)
0.77 (Rao et al. 2016)
0.70 (Rolle et al. 2019)
Circumpapillary
Whole image 0.89 (Jesus et al. 2019)
0.89 (Chen et al. 2017)
0.87 (Kwon et al. 2017)
0.53 (Kiyota et al. 2018)
Nasal 0.78 (Jesus et al. 2019)
Temporal 0.77 (Jesus et al. 2019)
Temporal superior 0.85 (Jesus et al. 2019)
Nasal superior 0.79 (Jesus et al. 2019)
Temporal inferior 0.87 (Jesus et al. 2019)
Nasal inferior 0.86 (Jesus et al. 2019)
2. Deep capillary plexus
Whole image/region 0.67 (Shin et al. 2017) 0.99 (Rabiolo et al. 2018)
0.99 (Rabiolo et al. 2018)
0.99 (Rabiolo et al. 2018)
0.97 (Rabiolo et al. 2018)
0.92 (Rabiolo et al. 2018)
0.86 (Yip et al. 2019)
0.79 (Rabiolo et al. 2018)
0.70 (Rabiolo et al. 2018)
0.70 (Lommatzsch et al. 2018)
0.70 (Alnawaiseh et al. 2018)
0.63 (Rao et al. 2017a)
0.70 (Lommatzsch et al. 2018)
Superior 0.63 (Shin et al. 2017) 0.69 (Lommatzsch et al. 2018)
0.69 (Lommatzsch et al. 2018)
Inferior 0.74 (Shin et al. 2017) 0.71 (Lommatzsch et al. 2018)
0.69 (Lommatzsch et al. 2018)
Nasal 0.52 (Shin et al. 2017) 0.71 (Lommatzsch et al. 2018)
0.71 (Lommatzsch et al. 2018)
Temporal 0.66 (Shin et al. 2017) 0.72 (Lommatzsch et al. 2018)
0.67 (Lommatzsch et al. 2018)
3. Whole retina
Whole image/region 0.96 (Yip et al. 2019)
0.93 (Akil et al. 2017)
0.91 (Rao et al. 2017c)
0.90 (Kurysheva et al. 2018)
0.86 (Akil et al. 2017)
0.84 (Kurysheva et al. 2018)†
0.82 (Rao et al. 2017c)*
0.77 (Rao et al. 2017c)†
0.74 (Alnawaiseh et al. 2018)
0.74 (Rao et al. 2017c)†
0.91 (Takusagawa et al. 2017)
4. Choriocapillaris
Whole image/region 0.84 (Alnawaiseh et al. 2018) 0.83 (Yarmohammadi et al. 2016a)
5. Choroid
Whole image/region 0.76 (Yip et al. 2019)
The bold font highlights all numerical values above the selected threshold (AUROC> 0.77). No values were reported for the avascular layer. The whole image/region is
deﬁned as all sectors combined.
*With Disc Haemorrhage.
†
Inside disc.
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to measure the risk of bias was per-
formed independently by two authors
(A.B. and E.F.). Criteria were com-
posed in cooperation with experienced
ophthalmologists (J.B.B. and I.S.;
Appendix B). The following six
aspects, ordered by relevance, were
considered:
1 Age. The age should not diﬀer
signiﬁcantly between the glaucoma
and the healthy groups. If there is an
age diﬀerence between groups, an
adjustment should be executed. Other-
wise, the outcomes are considered as
less reliable, because the microvascular
density decreases with age (Lin et al.
2019).
2 Eye. Measurements obtained from
both eyes of a subject are likely corre-
lated. Hence, unless proper statistical
methods are employed, there is a
higher risk of bias if both eyes are
included in the study.
3 Type and severity of glaucoma. Stud-
ies have a higher risk of bias when they
report combined results of primary and
secondary types of glaucoma, because
of the diﬀerence in pathophysiology.
Furthermore, the more severe the glau-
coma, the more advanced the damage,
not allowing to accurately infer the
sensitivity of the studied feature. This
means that a classiﬁcation problem
with high AUROC values for severe
glaucoma may not be a good predictor
for early diagnosis, even though they
could still be good features for follow‐
up.
4 OCT specifications. Diﬀerent hard-
ware speciﬁcations play a role in OCT
image quality, especially in deeper lay-
ers such as the choriocapillaris and the
choroid. Results from studies using
diﬀerent hardware should not be com-
pared to each other but rather dis-
cussed separately.
5 Image quality. Studies that included
images with SSI values (or similar
quality measures) below the suggested
inclusion value provided by the manu-
facturer are at higher risk of bias.
Suggested values by manufacturers:
for Angioplex, include if >6 (out of
10); for AngioVue, include if >45 (out
of 100) (Spaide et al. 2016).
6 Fovea‐disc axis correction. If a sec-
torial analysis is performed, fovea‐
disc axis correction should be exe-
cuted for all the OCTA images to
assure that the features are computed
for the same ROIs between subjects
(e.g. using a Panomap image; or any
other reference of the relative position
of the fovea and the optic disc
(Mwanza et al. 2015; Jesus et al.
2019)).
Results
Study selection
Ninety‐six studies were identiﬁed using
the search query in Appendix A. From
those, 53 studies were considered eligible
after screening the titles and abstracts.
Full‐text screening resulted in 43 studies
that met all inclusion criteria and, hence,
were eligible for thedata analysis (Fig. 2).
All the included studies provided a sta-
tistical analysis of the quantitative vas-
cular evaluation for diﬀerent ROIs.
Twenty‐four studies provided AUROC
as an outcome. The complete table with
the characteristics of the reviewed studies
can be found in Appendix B.
AUROC analysis
The AUROCs presented in the
reviewed studies are summarized in
Table 1 organized per layer, region
and sector. All studies calculated
AUROC values based on the microvas-
cular density, despite using diﬀerent
image processing techniques for inten-
sity quantiﬁcation or binarization.
Although the macular region showed
the highest AUROC values (consider-
ing all studies individually), when tak-
ing the mean of all ROIs, the
peripapillary region had the highest
AUROC of 0.80 ± 0.09, whereas the
macula and the optic disc both had
AUROC of 0.74 ± 0.12. The mean
AUROC values for all studied ROIs
are shown in Fig. 3. The average of all
AUROC values in Table 1 is 0.77,
which was set as the threshold for
deciding whether a study or ROI
should be further analysed in the qual-
itative assessment. All three regions
(optic disc, macular and peripapillary)
yielded values above this threshold, as
shown in Table 1. Table 1 also shows
that the avascular layer was not men-
tioned in any study, the choriocapillaris
only in two studies (Yarmohammadi
et al. 2016a; Alnawaiseh et al. 2018)
and the choroid in one study (Yip et al.
2019). On the other hand, the whole
retina, and the superﬁcial and deep
capillary plexuses have been investi-
gated frequently.
Macular region
For the whole image of the macula in
the superﬁcial layer, 10 out of 20 values
were reported above the threshold
(Chung et al. 2017; Takusagawa et al.
2017; Kurysheva et al. 2018; Lom-
matzsch et al. 2018; Rabiolo et al.
2018; Yip et al. 2019), and 6 out of 11
values were above the threshold in the
deep layer (Rabiolo et al. 2018; Yip
et al. 2019). Only one value above the
threshold was reported for the macula
in the whole retina (Takusagawa et al.
2017) and choriocapillaris (Alnawaiseh
et al. 2018).
Optic disc
The inside disc (Rao et al. 2017b;
Alnawaiseh et al. 2018) and the inferior
sector (Geyman et al. 2017; Shin et al.
2017) in the superﬁcial layer were the
ROIs with the highest AUROC, based
on the reports of two studies. The
whole region of the optic disc in the
whole retina layer had 7 out of 10
values above the threshold (Akil et al.
2017; Rao et al. 2017c; Kurysheva et al.
2018; Yip et al. 2019).
Peripapillary and circumpapillary region
The whole region (Yarmohammadi
et al. 2016a; Akil et al. 2017; Cen-
namo et al. 2017; Chung et al. 2017;
Triolo et al. 2017; Rao et al. 2017a;
Rao et al. 2017b; Rao et al. 2017d;
Kurysheva et al. 2018; Lommatzsch
et al. 2018; Rolle et al. 2019), supe-
rior (Akil et al. 2017; Chung et al.
2017; Rao et al. 2017d), inferior
(Chung et al. 2017; Triolo et al.
2017; Rao et al. 2017d) and temporal
inferior sectors (Rao et al. 2016; Shin
et al. 2017; Rao et al. 2017a; Rao
et al. 2017b; Kurysheva et al. 2018) in
the superﬁcial layer often presented
AUROC values above the threshold.
Also, for the whole region of the
circumpapillary ROI (circular band in
the peripapillary region) in the super-
ﬁcial layer, multiple values were
reported above the threshold (Chen
et al. 2017), (Kwon et al. 2017),
(Jesus et al. 2019). Only one AUROC
for the whole region in the chorio-
capillaris above the threshold (Yar-
mohammadi et al. 2016a) was
reported.
p‐value analysis
The results for the vascular density
diﬀered greatly between and within
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ROIs, as shown in Appendix C. Nev-
ertheless, a statistically signiﬁcant dif-
ference between control and glaucoma
groups was observed for all the
analysed ROIs. The number of statis-
tically signiﬁcant diﬀerences is summa-
rized in Fig. 4 (and detailed in Table C1
in Appendix C).
Macular region
The whole image of the macula in the
superﬁcial layer included 15 out of 17
signiﬁcant values. Five out of six values
reported for the whole image in the
deep layer were signiﬁcant. Only one
value, however signiﬁcant, was
reported for the choriocapillaris and
none for the choroid.
Optic disc
The inside disc sector in the superﬁcial
layer included nine signiﬁcant values
and only one non‐signiﬁcant. The infe-
rior segment in the superﬁcial layer
included only three values; however, all
of them are signiﬁcant. Only one out of
17 values reported a non‐signiﬁcant
diﬀerence for the whole image of the
optic disc in the superﬁcial layer. No
values were reported for the whole
image in the whole retina.
Peripapillary and circumpapillary region
The whole image in the superﬁcial layer
included 17 out of 19 signiﬁcant values.
The superior and inferior sectors of the
peripapillary region in the superﬁcial
layer were not represented as much in
the literature. However, all the studies
that analysed these regions reported a
signiﬁcant diﬀerence between the
groups (four and three values, respec-
tively). Seven out of eight values for the
temporal inferior sector in the superﬁ-
cial layer were signiﬁcant. No values
were reported for the whole region in
the choriocapillaris. Five out of ﬁve
values were reported as signiﬁcant for
the whole region of the circumpapillary
ROI in the superﬁcial layer. One value
was reported for the temporal superior,
temporal inferior and the nasal inferior
sectors in the superﬁcial layer, and all
three of them were signiﬁcant.
Qualitative assessment
The bold font in Table 1 highlights the
studies that provided one (or more)
AUROC values above the threshold.
The complete qualitative assessment
was performed in the 22 studies that
met the requirement of having an
AUROC> 0.77 (Appendix D). From
these study characteristics, it was pos-
sible to draw the following observa-
tions:
1 Age. Six studies (Rao et al. 2016;
Yarmohammadi et al. 2016a; Geyman
et al. 2017; Rao et al. 2017a; Rabiolo
Fig. 3. Mean AUROC and standard deviation value/number of observations for each ROI.
AUROC = area under the receiver operating characteristic curve, CC = choriocapillaris,
CH = choroid, cp = circumpapillary, DC = deep capillaris plexus, ROI = Regions of interest,
SC = superﬁcial capillaris, WR = whole retina.
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et al. 2018; Yip et al. 2019) reported a
signiﬁcant diﬀerence in age. However,
all of them performed age correction.
2 Eye. Ten studies (Rao et al. 2016;
Yarmohammadi et al. 2016a; Cennamo
et al. 2017; Rao et al. 2017a; Rao et al.
2017b; Rao et al. 2017c; Rao et al.
2017d; Alnawaiseh et al. 2018; Rabiolo
et al. 2018; Yip et al. 2019) included
both eyes from the same subject. All of
these studies except for Alnawaiseh
et al. (Alnawaiseh et al. 2018), Cen-
namo et al. (Cennamo et al. 2017) and
Yip et al. (Yip et al. 2019) mentioned to
have performed a correction for this.
Rolle et al. (Rolle et al. 2019) only
mentioned the number of eyes and not
the number of subjects included in the
study.
3 Type and glaucoma severity. No
patients with secondary glaucoma were
included in any of the studies. All studies
used a study population with diﬀerent
levels of glaucoma severity, however,
Chen et al. (Chen et al. 2017), Jesus
et al. (Jesus et al. 2019) andYip et al. (Yip
et al. 2019) used a patient group with a
relatively low visual ﬁeld mean deviation
(MD) (respectively, −8.8 ± 6.2 dB,
−7.8 ± 6.5 dB, and −11.07 ± 8.25 dB)
when compared to the other studies with
an average MD of −6.36 dB.
4 OCT specifications. All studies
acquired the images with an OCT
device with a light‐source wavelength
of 840 nm, except Akil et al. (Akil et al.
2017), Rabiolo et al. (Rabiolo et al.
2018) and Triolo et al. (Triolo et al.
2017) which used an OCT system with
a wavelength of 1040–1060 nm.
5 Image quality. Akil et al. (Akil et al.
2017) and Shin et al. (Shin et al. 2017)
did not report whether they used a cut‐
oﬀ value for exclusion due to image
quality. However, they did report that
5 and 10 images, respectively, were not
analysed because of poor OCTA image
quality. Eight studies (Rao et al. 2016;
Geyman et al. 2017; Rao et al. 2017a;
Rao et al. 2017b; Rao et al. 2017d;
Lommatzsch et al. 2018; Jesus et al.
2019; Yip et al. 2019) diﬀered from the
manufacturer’s suggested cut‐oﬀ value.
All these studies used a lower cut‐oﬀ
value than the standard recommended
value (Spaide et al. 2016).
6 Fovea‐disc axis correction. In none of
the studies that performed a sectorial
analysis, it was mentioned that a fovea‐
disc axis correction was performed,
except for Jesus et al. (Jesus et al.
2019).
Fig. 4. Number of studies with AUROC values> 0.77 for each ROI or that presented a signiﬁcant
(blue) and non‐signiﬁcant (orange) statistical diﬀerence between healthy and glaucoma groups for the
three regions; optic disc, macula and the peripapillary. AUROC = area under the receiver operating
characteristic curve, CC = choriocapillaris, CH = choroid, cp = circumpapillary, DC = deep capil-
laris plexus, ROI = Regions of interest, SC = superﬁcial capillaris, WR = whole retina.
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Discussion
This systematic review gives an insight
into which ROIs have been studied so
far in literature and which ones seem to
contribute the most to an accurate
diagnosis of glaucoma using microvas-
cular density computed from OCTA.
The ROIs in OCTA imaging were
deﬁned by three arguments: region of
acquisition, layer and sector.
The region of acquisition (macula,
optic disc or the peripapillary region)
should be the ﬁrst argument to be
considered in OCTA imaging, since it is
related to the ability to detect glauco-
matous vascular damage. Although the
highest AUROCs (considering all stud-
ies individually) were observed at the
macula, the peripapillary region
showed the highest AUROCs when
averaging all values per region of
acquisition. As mean AUROC is a
more reliable indicator than its maxi-
mum, we may conclude that the peri-
papillary region is the most relevant for
studying glaucomatous vascular dam-
age.
The second argument to be consid-
ered is the layer. Overall, the highest
AUROCs were obtained for the super-
ﬁcial layer. Nonetheless, the deeper
layers presented in some cases similar
classiﬁcation values to the superﬁcial
layer. However, the limited number of
studies that have covered these deeper
layers does not allow to draw conclu-
sions on their added value for the
diagnosis. These layers have been
avoided due to the diﬃculty to explain
the physical meaning of the imaged
content. As light travels deeper
through retinal tissue, it becomes more
susceptible to refraction and diﬀrac-
tion. Moreover, given the heterogeneity
of retinal tissue, light reﬂection and
absorption occur at diﬀerent levels
depending on the region of acquisition
and respective refraction index. As a
consequence, shadows are projected to
deeper layers, creating what is known
as projection artefacts. Therefore, and
despite the signiﬁcant diﬀerences
observed at the choriocapillaris and
the choroid, it is diﬃcult to conclude
whether these diﬀerences arise from the
pathology itself or are a consequence of
imaging artefacts. Further research
needs to be done in order to under-
stand to what extent the information
imaged by OCTA at deeper layers is
reliable.
The last argument, and the smallest
area, is the sector. A sectorial analysis
is not always performed in glaucoma-
tous vascular studies. A number of
studies have opted for analysing the
retinal layers, mainly the superﬁcial
vascular plexus, without any sector
discrimination. However, for those that
performed sectorial analysis, it was
shown that microvascular density is
aﬀected diﬀerently depending on the
sector. Taking the most studied region
of acquisition and layer as reference
(the superﬁcial layer of the peripapil-
lary region), it can be concluded from
this review that the inferior sector
(AUROC = 0.86 ± 0.03) and the supe-
rior sector (AUROC = 0.87 ± 0.10)
are the most promising at discriminat-
ing glaucoma. Moreover, Fig. 3 shows
that a sectorial circumpapillary analy-
sis (with a ﬁxed distance from the
optically hollow) seems to provide a
better discrimination than a sectorial
peripapillary conﬁguration (which
takes into account the entire scan).
Such a diﬀerence may be explained by
the reduced variability present in the
circumpapillary region, a speciﬁc cir-
cular ROI with ﬁxed dimensions
around the optic disc.
Overall, looking at the number of
studies that used OCTA information to
infer glaucomatous vascular damage
and the respective AUROCs, it can be
concluded that the whole region at the
superﬁcial layer of the peripapillary
ROI is the most accurate measurement
for glaucoma assessment, which could
be even further improved by a sectorial
circumpapillary analysis. This result
was somehow expected, since glaucoma
is characterized by a loss of optic nerve
axons, which traverse the retina super-
ﬁcially in an anatomical area included
in the OCTA’s superﬁcial layer. More-
over, all the axons meet at the optic
nerve which makes a circumpapillary
analysis at the peripapillary ROI the
best option to capture information
from all of them at the same time.
Macular scans are indeed relevant but
can miss damage that falls outside the
macular scan area (Van Melkebeke
et al. 2018).
Nevertheless, a certain discrepancy
and conﬂicting results have also been
observed between sectors at diﬀerent
layers and regions of acquisition.
Possible reasons for such a variability
are related to the data and respective
study design, and were qualitatively
evaluated. Although no signiﬁcant dif-
ferences were observed in terms of age
(except for one study which did not
provide information (Rolle et al.
2019)), it was noted that three studies
(Cennamo et al. 2017; Rao et al. 2017b;
Alnawaiseh et al. 2018) used both eyes
of the same subject, without mention-
ing any correction (Appendix D). Age
and inclusion of both eyes can consti-
tute a source of bias in the results, since
the microvascular density decreases
with age, and the data from both eyes
are highly correlated. No secondary
types of glaucoma were included in any
of the reviewed studies. However, three
of them (Chen et al. 2017; Jesus et al.
2019; Yip et al. 2019) used a glaucoma
group with a relatively low visual ﬁeld
MD (−7.8 dB and lower) which may
lead discrepancy between results. The
comparison of diﬀerent regions with
data from groups with diﬀerent sever-
ity groups may contribute to the mis-
interpretation of the data, as the more
severe the glaucoma, the more
advanced the damage is. Furthermore,
three studies (Akil et al. 2017; Triolo
et al. 2017; Rabiolo et al. 2018) used a
1040 nm OCT device and achieved a
high diagnostic accuracy. All of these
devices were Swept‐Source OCT
(SSOCT) which could potentially indi-
cate that a SSOCT may provide a
better OCTA image quality and, con-
sequently, may result in higher AUR-
OCs. Further research is recommended
to conﬁrm the advantages of using
SSOCT for OCTA imaging in assessing
glaucomatous microvascular damage.
A high risk of bias was identiﬁed in
eight studies that included images with
an image quality below the threshold
suggested by the manufacturer (see
Appendix D). Two other studies did
not report which threshold was used.
Only one study performed a fovea‐disc
axis correction (Jesus et al. 2019). Due
to eye motion or slight diﬀerences in
position during image acquisition,
OCTA images from diﬀerent subjects
might not match the same sectors at the
same location. Therefore, sectorial
analysis requires images to be previ-
ously corrected, for instance taking the
fovea‐disc axis into account. This way
all subjects will have the same reference
point for the sectorial analysis.
Another reason for the current vari-
ability between studies is related to the
method employed to extract vascular
density. Although it is not the focus of
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this review, diﬀerent image processing
approaches can lead to diﬀerent vascu-
lar interpretations within the same
subject data. A popular method among
the community is the OCTA image
binarization based on thresholding
techniques. The ratio of white or black
pixels over a speciﬁc area is used to
estimate the microvascular dropout. In
general, the threshold is chosen based
on an empirical analysis using an image
processing programme such as ImageJ
(Abràmoﬀ et al. 2004). The separation
of micro‐ from macrovasculature is
another source of variability between
studies. In some studies, the macrovas-
culature is segmented and removed
from the region of acquisition. Other
authors have opted for estimating vas-
cular density based on all the informa-
tion presented on the OCTA image.
Macrovasculature is not expected to be
aﬀected by glaucoma, and it is a
subject‐dependent anatomical feature.
Thus, an analysis on image pixel inten-
sity including macrovasculature is not
desirable, as it may bias the results.
Similarly, the optically hollow area
inside the optic disc, as well as the
foveal avascular zone (FAZ), is sub-
ject‐dependent. Therefore, it is desir-
able to segment and exclude these areas
from the ROI before the microvascular
density estimation is performed. Nev-
ertheless, further research is needed for
a better understanding of the variabil-
ity between mathematical approaches
and to understand which is the most
appropriated for glaucoma diagnosis.
Although a few research lines have
already considered more complex pro-
cedures, such as fractal analysis
(Gadde et al. 2016), replication studies
are still needed to evaluate such
advanced/complex methods.
The superior and inferior sectors of
the superﬁcial layer of the peripapillary
region may be suitable for the diagno-
sis. However, the averaged AUROC
reported in the reviewed articles is still
lower than the values obtained with
retinal nerve ﬁbre layer thickness (mea-
sured through standard OCT imaging)
and lower than the optic disc features
(extracted from fundus imaging
(Hemelings et al. 2020)), which usually
result in AUROC values higher than
0.9. Nevertheless, recent studies have
shown that vascular density assessed
by OCTA seems to perform better
than the gold standard biomarkers at
discriminating advanced cases of
glaucoma (Barbosa‐Breda et al. 2018;
Van Melkebeke et al. 2018). Hence,
follow‐up of (advanced) glaucoma
using OCTA imaging may be a window
of opportunity to establish OCTA as a
common practice in the clinical envi-
ronment. Thus, new studies will be
required to infer which OCTA ROI is
the best at glaucoma follow‐up.
Conclusions
This review provides a comprehensive
summary of the research on glaucoma-
tous microvascular damage based on
the analysis of diﬀerent ROIs imaged
with OCTA. The collected data show
that the superﬁcial layer in the peri-
papillary region is the most informative
to infer vascular damage. Furthermore,
at this location and layer, the inferior
and superior sectors have been found
as the most discriminative ROIs to
study glaucomatous vascular damage
with OCTA.
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Appendix A
Search query used in the PubMed
database:
("Glaucoma*"[Mesh] OR “Glau-
coma*”[tiab]) AND ("optical coher-
ence tomography angiography"[tiab]
OR "OCTA"[tiab] OR “OCT‐A”[tiab]
OR “OCT angiography”[tiab] OR
“optical coherence tomography based
microangiography”[All Fields] OR
“angio‐OCT”[tiab] OR “OCT‐angio”[-
tiab]) AND ("Glaucoma/diagnostic
imaging"[Mesh] OR "Glaucoma/diag-
nosis"[Mesh] OR "Glaucoma/analy-
sis"[Mesh] OR "Image Analysis"[tiab]
OR "Image Processing"[tiab] OR
"Image Enhancement"[Mesh] OR
"Image Enhancement"[tiab] OR
“Image processing, Computer
Assisted”[Mesh] OR “Image process-
ing, Computer Assisted”[tiab]OR
"Computer‐Assisted Image Process-
ing"[Mesh] OR "Computer‐Assisted
Image Processing"[tiab]OR "Com-
puter Assisted Image Process-
ing"[Mesh] OR "Computer Assisted
Image Processing"[tiab]OR "Image
Reconstruction"[Mesh] OR "Image
Reconstruction"[tiab] OR "Image
Reconstructions"[Mesh] OR "Image
Reconstructions"[tiab] OR "Recon-
struction, Image"[Mesh] OR "Recon-
struction, Image"[tiab]OR
"Reconstructions, Image"[Mesh] OR
"Reconstructions, Image"[tiab]
OR"Image Analysis, Computer‐
Assisted"[tiab]OR "Image Analysis,
Computer Assisted"[Mesh] OR "Image
Analysis, Computer Assisted"[tiab]OR
"Computer‐Assisted Image Analy-
sis"[Mesh] OR "Computer‐Assisted
Image Analysis"[tiab]OR "Computer
Assisted Image Analysis"[Mesh] OR
"Computer Assisted Image Analysis"[-
tiab]OR "Analysis, Computer‐Assisted
Image"[Mesh] OR "Analysis, Com-
puter‐Assisted Image"[tiab]OR "Com-
puter‐Assisted Image Analyses"[Mesh]
OR "Computer‐Assisted Image Anal-
yses"[tiab]OR "Image Analyses, Com-
puter‐Assisted"[Mesh] OR "Image
Analyses, Computer‐Assisted"[tiab]
OR “Algorithm*”[tiab] OR “mi-
crovascular density”[tiab])
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Appendix C
Table C1. Vessel density values (%) for healthy control group (bold) versus glaucoma patients according to the ocular layer, region and sector. Some
studies provided multiple values for the same area due to comparison between approaches or diﬀerent glaucoma types. The radial peripapillary
capillary plexus is shown here as sublayer of the superﬁcial capillary plexus.
Sector
Region
Optic Disc Macular Region Peripapillary region
1.a Radial peripapillary capillary plexus
Whole image 14.6 versus 5.3 (Yip et al. 2017)
51.8 versus 47.3 (Rabiolo et al.,
2018)
49.3 versus 46.7 (Rabiolo et al.
2018)
49.5 versus 43.4 (Rabiolo et al.
2018)
48.1 versus 41.9 (Rabiolo et al.
2018)
49.7 versus 37.1 (Rabiolo et al.
2018)
40.8 versus 39.3 (Rabiolo et al.
2018)
55.42 versus 50.58 (Alnawaiseh
et al. 2018)†
53 versus 54 (Triolo et al. 2017)
53 versus 50 (Triolo et al. 2017)
55.8 versus 52.9 versus 43.1
(Kurysheva et al. 2016)
53.9 versus 45.2 (Rao et al.
2017c)*
58.8 versus 55.4 versus 48.6
versus 43.1 versus 36.5 (Kumar
et al. 2019)
54.4 versus 50.4 (Rao et al. 2016)
53.9 versus 45.1 (Rao et al.
2017a)*
58.09 versus 54.01 (Alnawaiseh
et al. 2018)†
86.6 versus 78.04 versus 70.1
(Akil et al. 2017)
61.9 versus 54.4 (Rao et al.
2017c)*
47 versus 40 versus 46 (Chen
et al. 2016)
63.62 versus 56.15 (Zhu et al.
2015)
48.03 versus 46.09 versus 45.34
versus 42.36 (Chung et al.
2017)
62 versus 55 (Rao et al. 2016)
53.3 versus 43.8 (Chen et al.
2017)
40.7 versus 37.9 (Nascimento
et al., 2019)
63.07 versus 59.99 (Alnawaiseh
et al. 2018)*
60.8 versus 52.5 versus 52.7
(Rao et al. 2018)*
58.0 versus 56.9 versus 46.3
(Kurysheva et al. 2016)
61.9 versus 53.3 (Rao et al.
2017a)*
65.28 versus 60.34 (Rolle et al.
2017d)
93 versus 80.55 (Liu et al. 2019)
49.8 versus 38.2 versus 42.1
(Chihara et al. 2017)
86.6 versus 86.83 versus 80.03
(Akil et al. 2017)
42.2 versus 35.1 versus 30.8
versus 28.3 (Geyman et al.
2017)‡
42.3 versus 30.2 (Fard et al.
2018)‡
53.01 versus 44.73 (Liu et al.
2015)
56.7 versus 51.6
(Yarmohammadi et al. 2016a)
56.7 versus 48.3
(Yarmohammadi et al. 2016a)
56.7 versus 41.7
(Yarmohammadi et al. 2016a)
41.32 versus 36.49 (Scripsema
et al. 2019)‡
41.32 versus 33.13 (Scripsema
et al. 2019)‡
41.88 versus 36.48 (Scripsema
et al. 2019)‡
41.88 versus 33.31 (Scripsema
et al. 2019)‡
55.70 versus 51.87 (Poli et al.
2019)
55.70 versus 46.21 (Poli et al.
2019)
55.70 versus 37.45 (Poli et al.
2019)
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Table C1. (Continued)
Sector
Region
Optic Disc Macular Region Peripapillary region
not signiﬁcant (Rao et al.
2017b; Poli et al. 2019; Rolle
et al. 2017d)
Inside Disc 20.9 versus 11.0 (Yip et al. 2017)
55.45 versus 49.09 (Rolle et al.
2017d)
48.1 versus 40.1 (Rao et al.
2017c)*
48.1 versus 46.5 (Rao et al.
2017a)*
46,78 versus 34.07 (Alnawaiseh
et al. 2018)*
47.4 versus 40.2 (Rao et al. 2016)
77 versus 68 versus 70 (Bojikian
et al. 2016)
50.2 versus 45.3 versus 37.7
(Kurysheva et al. 2016)
37.9 versus 39.8 versus 29.8
versus 29.8 versus 26.7 (Kumar
et al. 2019)
Not signiﬁcant (Nascimento
et al., 2019; Rolle et al. 2017d)
Inferior 23.1 versus 13.3 (Yip et al. 2017)
64.7 versus 53.9 (Rao et al.
2017c)*
48.7 versus 43.7 (Rao et al.
2017a)*
64.7 versus 53.9 (Rao et al.
2017c)*
46 versus 37 versus 46 (Chen
et al. 2016)
63.26 versus 59.72 (Zhu et al.
2015)
44.3 versus 36.7 versus 30.5
versus 24.7 (Geyman et al.
2017)‡
43.9 versus 36.1 (Fard et al.
2018)‡
Superior 21.4 versus 12.7 (Yip et al. 2017)
49.1 versus 40.8 (Rao et al.
2017c)*
49.1 versus 49.5 (Rao et al.
2017a)*
63.6 versus 55.2 (Rao et al.
2017c)*
45 versus 39 versus 46 (Chen
et al. 2016)
43.6 versus 35.2 versus 30.3
versus 26.3 (Geyman et al.
2017)‡
43.7 versus 29.1 (Fard et al.
2018)‡
Nasal superior 63.26 versus 59.72 (Zhu et al.
2015)
63.91 versus 60.71 versus 57.84
versus 49.42 (Chung et al.
2017)
62.9 versus 55.3 (Rao et al.
2016)
59.1 versus 51.8 versus 53.0
(Rao et al. 2018)*
55.6 versus 54.7 versus 44.8
(Kurysheva et al. 2016)
59.4 versus 51.8 (Rao et al.
2017a)*
not signiﬁcant (Mansoori et al.
2018; Rao et al. 2017b)‡
Nasal inferior 64.40 versus 55.85 (Zhu et al.
2015)
65.80 versus 60.94 versus 59.11
versus 45.07 (Chung et al.
2017)
Table C1. (Continued)
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Table C1. (Continued)
Sector
Region
Optic Disc Macular Region Peripapillary region
63.4 versus 55.2 (Rao et al.
2016)
62.0 versus 53.8 versus 53.1
(Rao et al. 2018)*
62.1 versus 59.2 versus 54.4
(Rao et al. 2017b)
55.8 versus 57.6 versus 45.0
(Kurysheva et al. 2016)
61.2 versus 54.3 (Rao et al.
2017a)*
not signiﬁcant (Mansoori et al.
2018)‡
Nasal 17.3 versus 8.2 (Yip et al. 2017)
48.9 versus 41.2 (Rao et al.
2017c)*
48.9 versus 44.2 (Rao et al.
2017a)*
59.5 versus 53.2 (Rao et al.
2017c)*
61.39 versus 54.61 (Zhu et al.
2015)
60.23 versus 59.21 versus 55.80
versus 48.77 (Chung et al.
2017)
59.7 versus 56 (Rao et al. 2016)
58.0 versus 51.2 versus 51.9
(Rao et al. 2018)*
56.9 versus 54.8 versus 46.5
(Kurysheva et al. 2016)
42.8 versus 35.5 versus 33.2
versus 29.8 (Geyman et al.
2017)‡
43.3 versus 32.2 (Fard et al.
2018)‡
not signiﬁcant (Chen et al.
2016; Rao et al. 2017b)
Temporal
superior
66.25 versus 58.36 (Zhu et al.
2015)
68.82 versus 64.15 versus 56.55
versus 43.31 (Chung et al.
2017)
66.6 versus 59.4 (Rao et al.
2016)
63.3 versus 56.5 versus 53.5
(Rao et al. 2018)*
60.4 versus 59.0 versus 49.2
(Kurysheva et al. 2016)
64.9 versus 56.9 (Rao et al.
2017a)*
20.2 versus 10.8 (Mansoori
et al. 2018)‡
not signiﬁcant (Rao et al.
2017b)
Temporal
inferior
66.95 versus 60.11 (Zhu et al.
2015)
68.52 versus 64.93 versus 61.04
versus 49.15 (Chung et al.
2017)
66 versus 55.5 (Rao et al. 2016)
64.6 versus 49.7 versus 52.8
(Rao et al. 2018)*
60.5 versus 59.8 versus 44.4
(Kurysheva et al. 2016)
20.7 versus 13.4 (Mansoori
et al. 2018)‡
63.0 versus 51.8 (Rao et al.
2017a)*
Table C1. (Continued)
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Table C1. (Continued)
Sector
Region
Optic Disc Macular Region Peripapillary region
not signiﬁcant (Rao et al.
2017b)
Temporal 17.3 versus 11.0 (Yip et al. 2017)
44.3 versus 34.9 (Rao et al.
2017c)*
44.3 versus 36.9 (Rao et al.
2017a)*
60.3 versus 56.5 (Rao et al.
2017c)*
68.83 versus 64.16 versus 62.13
versus 50.55 (Chung et al.
2017)
60.4 versus 57 (Rao et al. 2016)
59.0 versus 55.0 versus 53.6
(Rao et al. 2018)*
59.4 versus 58 versus 47
(Kurysheva et al. 2016)
45.2 versus 41.3 versus 37.5
versus 36.2 (Geyman et al.
2017)‡
44.6 versus 28.2 (Fard et al.
2018)‡
not signiﬁcant (Rao et al. 2017b)
Circumpapillary
Whole image
34 versus 24 (Jesus et al. 2017)*
61.5 versus 53.3 (Chen et al.
2017)
51.9 versus 39.5 versus 34.4
(Kwon et al. 2018)
62.4 versus 59 versus 54.7
(Yarmohammadi et al. 2016b)
64.2 versus 60.3 versus 55.1
(Yarmohammadi et al. 2018)
65.1 versus 57.5
(Yarmohammadi et al. 2016a)
65.1 versus 49.6
(Yarmohammadi et al. 2016a)
42.45 versus 37.20 (Scripsema
et al. 2019)‡
42.45 versus 33.40 (Scripsema
et al. 2019)‡
42.99 versus 37.75 (Scripsema
et al. 2019)‡
42.99 versus 34.24 (Scripsema
et al. 2019)‡
not signiﬁcant
(Yarmohammadi et al. 2016a)
Temporal 30 versus 23 (Jesus et al. 2017)*
62.1 versus 55.3 (Chen et al.
2017)
not signiﬁcant (Liu et al. 2015)
Temporal
inferior
66.4 versus 46.2 (Chen et al.
2017)
67.29 versus 46.39 (Liu et al.
2017)
Temporal
superior
66.0 versus 55.9 (Chen et al.
2017)
64.78 versus 54.47 (Liu et al.
2015)
Superior 34 versus 23 (Jesus et al. 2017)*
62.01 versus 55.37 (Liu et al.
2015)
Nasal 30 versus 24 (Jesus et al. 2017)*
not signiﬁcant (Chen et al.
2017; Liu et al. 2015)
Nasal inferior 63.6 versus 51.8 (Chen et al.
2017)
Table C1. (Continued)
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Table C1. (Continued)
Sector
Region
Optic Disc Macular Region Peripapillary region
62.23 versus 54.66 (Liu et al.
2015)
Nasal superior 59.2 versus 54.7 (Chen et al.
2017)
not signiﬁcant (Liu et al. 2015)
Inferior 38 versus 23 (Jesus et al. 2017)*
64.76 versus 50.53 (Liu et al.
2015)
1. Superﬁcial capillary plexus
Whole image Not signiﬁcant (Nascimento
et al., 2019)
46.89 versus 42.31 (Lommatzsch et al. 2017)
44 versus 40 (Lommatzsch et al. 2017)
43.2 versus 38.5 (Chen et al. 2017)
46.21 versus 39.55 (Zivkovic et al. 2018)
52.51 versus 48.89 (Alnawaiseh et al. 2018)*
58.02 versus 52.37 (Rolle et al. 2017d)
58.02 versus 49.09 (Rolle et al. 2017d)
48.3 versus 44.7 (Rao et al. 2016)*
49.8 versus 47.5 (Rao et al. 2016)
11.5 versus 8.8 (Yip et al. 2017)
37.3 versus 31.8 (Kromer et al. 2017)
60.5 versus 47.2 (Takusagawa et al. 2010)
53.77 versus 51.63 (Alnawaiseh et al. 2018)*
50.7 versus 45.9 versus 42.2 (Kurysheva et al. 2016)
49.5 versus 46.9 (Rao et al. 2017c)*
53.8 versus 51.1 versus 48.3 (Yarmohammadi et al.
2016b)
50.83 versus 46.99 (Zhu et al. 2015)
52.27 versus 50.83 versus 47.15 versus 45.46 (Chung
et al. 2017)
49.5 versus 46.6 (Rao et al. 2017a)*
43.11 versus 38.46 (Liu et al. 2015)
not signiﬁcant (Chen et al. 2017; Triolo et al. 2017)
56.6 versus 51.3 versus 46.2
(Yarmohammadi et al. 2018)
Superior 50.3 versus 47.5 (Rao et al. 2017c)*
51.60 versus 47.62 (Zhu et al. 2015)
49.2 versus 49.7 (Rao et al. 2017a)*
52.65 versus 51.60 versus 47.64 versus 45.74 (Chung
et al. 2017)
50.8 versus 47.6 (Rao et al. 2016)
51.60 versus 47.62 (Zhu et al. 2015)
53.2 versus 47.3 versus 47.4 (Kurysheva et al. 2016)
not signiﬁcant (Liu et al. 2015; Triolo et al. 2017;
Kromer et al. 2017)
Nasal 48.3 versus 45.9 (Rao et al. 2017c)*
48.5 versus 47 (Rao et al. 2016)
50.57 versus 45.99 (Zhu et al. 2015)
51.2 versus 46.8 versus 46.3 (Kurysheva et al. 2016)
52.24 versus 50.58 versus 47.87 versus 46.85 (Chung
et al. 2017)
56.2 versus 43.58 (Kromer et al. 2017)
not signiﬁcant (Chen et al. 2017; Liu et al. 2015)
Temporal 49.6 versus 46.8 (Rao et al. 2017c)*
52.64 versus 51.13 versus 47.36 versus 46.05 (Chung
et al. 2017)
59.7 versus 56.0 (Rao et al. 2016)
49.8 versus 47.3 (Rao et al. 2016)
51.95 versus 48.18 (Zhu et al. 2015)
52.4 versus 47.2 versus 46.1 (Kurysheva et al. 2016)
43.06 versus 39.71 (Liu et al. 2015)
not signiﬁcant (Chen et al. 2017; Kromer et al. 2017)
Inferior 51.0 versus 46.6 (Rao et al. 2017c)*
49.3 versus 48.9 (Rao et al. 2017a)*
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Table C1. (Continued)
Sector
Region
Optic Disc Macular Region Peripapillary region
51.38 versus 50.29 versus 46.17 versus 44.11 (Chung
et al. 2017)
60.4 versus 57 (Rao et al. 2016)
48.5 versus 47 (Rao et al. 2016)
50.57 versus 45.99 (Zhu et al. 2015)
51.2 versus 46.8 versus 46.3 (Kurysheva et al. 2016)
not signiﬁcant (Chen et al. 2017; Liu et al. 2015; Triolo
et al. 2017; Kromer et al. 2017)
Fovea 36.4 versus 32.1 versus 30.8 (Kurysheva et al. 2016)
53.61 versus 47.23 (Poli et al. 2019)
53.61 versus 41.98 (Poli et al. 2019)
53.61 versus 39.89 (Poli et al. 2019)
not signiﬁcant (Chen et al. 2017; Alnawaiseh et al. 2018;
Lommatzsch et al. 2017; Poli et al. 2019; Kromer et al.
2017)*
2. Deep capillary plexus
Whole image 44.1 versus 39.4 (Nascimento
et al., 2019)
53.28 versus 48.23 (Lommatzsch et al. 2017)
56.97 versus 54.95 (Alnawaiseh et al. 2018)*
23.3 versus 13.6 (Yip et al. 2017)
30.6 versus 30.2 (Kromer et al. 2017)
57.3 versus 52.2 versus 46.6 (Kurysheva et al. 2016)
not signiﬁcant (Takusagawa et al. 2010)
59.93 versus 57.07 (Alnawaiseh
et al. 2018)*
Superior 62.1 versus 57 versus 54.1 (Kurysheva et al. 2016)
not signiﬁcant (Kromer et al. 2017)
Temporal 60 versus 55.8 versus 54.1 (Kurysheva et al. 2016)
not signiﬁcant (Kromer et al. 2017)
Inferior 59.3 versus 56 versus 52 (Kurysheva et al. 2016)
not signiﬁcant (Kromer et al. 2017)
Nasal 59.6 versus 56.3 versus 50.7 (Kurysheva et al. 2016)
not signiﬁcant (Kromer et al. 2017)
Fovea 33.3 versus 30.11 (Lommatzsch et al. 2017)
29.45 versus 31.75 (Alnawaiseh et al. 2018)*
35.4 versus 32.5 versus 26.3 (Kurysheva et al. 2016)
not signiﬁcant (Kromer et al. 2017)
3. Choriocapillaris
Whole image 22.5 versus 15.3 (Yip et al. 2017)
Inferior 22.2 versus 15.8 (Yip et al. 2017)
Superior 22.8 versus 15.1 (Yip et al. 2017)
Nasal 22.9 versus 15.3 (Yip et al. 2017)
Temporal 24.3 versus 15.1 (Yip et al. 2017)
4. Choroid
Whole image 22.8 versus 16.5 (Yip et al. 2017) 63.2 versus 64.2 versus 57.9
(Kim et al. 2000)
Temporal
inferior
68.4 versus 64.7 versus 48.37
(Kim et al. 2000)
Temporal
superior
not signiﬁcant (Kim et al. 2000)
Superior 26 versus 17.8 (Yip et al. 2017)
Nasal 23.6 versus 17.3 (Yip et al. 2017)
Temporal 19.2 versus 13.1 (Yip et al. 2017)
Inferior Not signiﬁcant (Yip et al. 2017)
5. Whole retina
Whole image 51.58 versus 47.27 versus 45.56 (Xu et al. 2014)§ 63.29 versus 55.57 versus 49.78
(Xu et al. 2014)§
All values are in mean, except when speciﬁed diﬀerently. Value were considered as signiﬁcant at a cut-oﬀ of <0.05
* Values given in median.
† Whole enface.
‡ Large vessels extracted, capillary density.
§ Not further speciﬁed which layer was used.
Table C1. (Continued)
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Appendix D
Table D1. Qualitative assessment for the studies with an AUROC value above the threshold of 0.77.
Author Age Eye
Types and glaucoma severity
(VF MD, dB)
OCT
speciﬁcations
Image Quality
cut-oﬀ
Fovea-Disc
axis
Akil et al. (2017) No No POAG: 2.8  1.9
PPG: 1.65  2.25
1050 NA* Yes
Alnawaiseh et al. (2017) No Yes 2.74 (5.17, 1.25)† 840 <50 No, NA
Cennamo et al. (2017) No Yes 0.15  1.17 840 <50 No, NA
Chen et al. (2017) No No –8.8  6.2 840 <45 Yes
Chung et al. (2017) No No Early: 2.42  1.69
Moderate: 8.35  1.77
Severe: 20.12  5.31
840 <50 Yes
Geyman et al. (2017) Yes,
corrected
No Mild: 3.2  1.7
Moderate: 8.0  2.0
Severe: 21.4  7.1
840 <40 Yes
Jesus et al. (2019) No No –7.8  6.5 840 <6‡ No
Kurysheva et al. (2016) No No Early POAG: 2.1  3.4
Moderate/Severe POAG:
11.8  6.1
840 <50 Yes
Kwon et al. (2018) No No PVFD: 4  4
CVFD: 3.2  2.2
840 <8‡ No, NA
Lommatsch et al. (2017) Yes,
corrected
no AngioVue group:  4.8  6.31
AngioPlex group:  4.63  5.7
840 <40 Yes
Rabiolo et al. (2018) Yes,
corrected
yes, corrected NA 1040–1060 <7§ No, NA
Rao et al. (2018) Yes,
corrected
yes, corrected –5.3 (9.6, 3.1)† 840 <35 Yes
Rao et al. (2016) Yes,
corrected
yes, corrected POAG: 6.3 (13.5, 3.1)†
PACG: 9.2 (16.0, 3.3)†
840 <40 Yes
Rao et al. (2017c) NO Yes, corrected –6.3 (12.5, 3.5)† 840 <35 Yes
Rao et al. (2017a) No Yes, corrected PAC: 1.9 (3.6, 0.8)†
PACG: 8.2 (16.0, 4.0)†
840 <35 Yes
Rao et al. (2017b) No Yes, corrected POAG with DH: 3.7 (6.3,
2.5)†
POAG without DH: 3.8 (7.5,
2.8)†
840 <45 Yes
Rolle et al. (2017d) No Number of patients
NA
PPG: 0.96  1.15
POAG: 4.63  3.53
840 <50 Yes
Shin et al. (2016) No No –5.88  6.01 840 NA‡ Yes
Takusagawa et al. (2010) No No –5.32  3.50 840 <50 No, NA
Triolo et al. (2017) No No –5.45  2.27 1040–1060 <7§ Yes
Yarmohammadi et al.
(2018,b)
Yes,
corrected
Yes, corrected –3.9 (8.8, 1.8)† 840 <48 No, NA
Yip et al. (2017) Yes,
corrected
Yes –11.07  8.25 840 <40
If a risk of bias for age or eye existed, yes was ﬁlled in. All values for visual ﬁeld mean deviation are given in mean  SD, unless indicated otherwise.
All images were acquired using AngioVue OCTA device, unless indicated otherwise. Corrections for age and/or the use of both eyes for one subject
are presented in the table when executed (corrected). If no sector analysis was executed in the study, a fovea-disc axis correction was considered as
unnecessary or not applicable (NA). Study characteristics that may bias the results are given in bold.
CFVD = central visual ﬁeld defect, DH = disc haemorrhage, MD = mean deviation, PACG = primary angle closure glaucoma, PFVD = peripheral
visual ﬁeld defect, POAG = primary open-angle glaucoma, PPG = preperimetric glaucoma, VF = visual ﬁeld.
* DRI OTC, Triton, Topcon.
† Values in median (IQR).
‡ Cirrus-HD-OCT-5000, Zeiss Angioplex.
§ SS-OCTA PLEX Elite 9000, Zeiss.
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